Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ivim Health vs Voxy

Ivim Health
Graded #338

Lower grade

vs+2.799999999999997
Voxy
Graded #272

Higher grade

The verdict

Voxy takes it — 62.4/100 to 59.6/100.

Voxy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Voxy is a Scottsdale, Arizona telehealth practice offering compounded semaglutide and tirzepatide alongside NAD+ and sermorelin.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVoxy +7
44
51
Dose & formulationEven
64
64
Clinical oversightVoxy +3
79
82
Labs & monitoringVoxy +11
52
63
FulfillmentVoxy +13
65
78
Contract termsIvim Health +35
55
20
Ivim Health · left barVoxy · right bar

The numbers

MetricIvim HealthVoxy
WeighScore59.6/10062.4/100
GradeCC
Scorecard rank#338#272
Semaglutide$149/mo (starting dose, medication and programme fee, compounded)$179/mo (compounded)
Tirzepatide$224/mo (starting dose, medication and programme fee, compounded)$299/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Ivim Health

Graded #338 · C

Strengths

  • Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
  • A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
  • The first month of the membership is free

Where it loses points

  • A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
  • The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
  • Both figures are 'starting at' rates, so the cost of a titrated dose is not published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Voxy

Graded #272 · C

Strengths

  • Names both its compounding pharmacy (VialsRX, Houston TX) and its prescribing medical group (Arora Health & Aesthetics) — most name neither
  • Publishes the full price ladder for both drugs across 1-, 3-, 6- and 12-month terms before you start the assessment
  • One price covers the provider visit, medication, injection supplies, shipping and monthly check-ins — no separate membership fee
  • True month-to-month option at $179 semaglutide / $299 tirzepatide with no commitment required
  • Free assessment with no charge to see if you qualify, and no labs required to start

Where it loses points

  • No terms of service anywhere on the site — /terms, /terms-of-service and /terms-of-use all return 404
  • No refund policy published; the only stated commitment language is 'cancel anytime'
  • Advertised 'Starting at $129/mo' is the 12-month prepay rate — month-to-month is $179 semaglutide and $299 tirzepatide
  • No public list of states served; availability depends on where affiliated providers are licensed
  • The prescribing nurse practitioner is not named — 'provider details available during your consultation'

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard